EU approves Roche drug Columvi for lymphoma treatment
This content was published on
The European Commission has approved Roche's Columvi as the first bispecific antibody for the treatment of diffuse large B-cell lymphoma after initial therapy.
Novartis announces billion-dollar investments in the US
This content was published on
Swiss pharmaceutical company Novartis plans to invest a total of $23 billion in the US over the next five years to expand production and research.
This content was published on
Vitol generated earnings of over $8bn in 2024, cementing its position as by far the most profitable energy trading house.
Nestlé’s French Perrier water licence under threat
This content was published on
Nestlé may have to stop marketing French mineral water Perrier after using filtering methods illegal for natural mineral waters.
“No US tariff negotiations”: Swiss economics minister
This content was published on
Switzerland has yet to enter formal tariff negotiations with the United States despite making contact with the administration.
Soaring cocoa prices hit Swiss chocolate maker Barry Callebaut
This content was published on
Swiss chocolate maker Barry Callebaut suffered from soaring cocoa prices in the first half of the 2024-2025 financial year.
Nestlé Waters scandal: Élysée Palace ‘knew of misconduct’
This content was published on
An inquiry revealed that the French presidency granted Swiss company Nestlé Waters access to ministries despite knowing about their misconduct.